SPONSOR
National University of Singapore
Total Trials
5
Recruiting
5
Phases
Phase 2, Phase 3, Phase 4
Conditions studied: StrokeIntracranial AtherosclerosisStroke, IschemicBloodstream InfectionVentilator Associated Bacterial PneumoniaHospital Acquired Bacterial PneumoniaCarbapenem Resistant Bacterial InfectionMultidrug ResistanceAtopic DermatitisAtopic
National University of Singapore is a clinical research sponsor with 5 registered studies on ClinicalTrials.gov, of which 5 are actively recruiting participants. Research covers conditions including Stroke, Intracranial Atherosclerosis, Stroke, Ischemic, Bloodstream Infection.
The trial portfolio spans Phase 2, Phase 3, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — National University of Singapore
How many clinical trials has National University of Singapore sponsored?
ClinicalMetric currently tracks 5 clinical trials sponsored by National University of Singapore, of which 5 are actively recruiting participants. These trials cover conditions including Stroke, Intracranial Atherosclerosis, Stroke, Ischemic. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does National University of Singapore research focus on?
National University of Singapore clinical trials span Stroke, Intracranial Atherosclerosis, Stroke, Ischemic, Bloodstream Infection, Ventilator Associated Bacterial Pneumonia, and additional conditions. The research pipeline includes Phase 2, Phase 3, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a National University of Singapore clinical trial?
To participate in a National University of Singapore trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all National University of Singapore trials with current recruitment status updated daily.
Clinical Trials by National University of Singapore
NCT07116187
Recruiting
A Pilot Return-to-Work Cognitive Intervention After Stroke
Stroke
NCT07282041 Phase 2, Phase 3
Recruiting
Role of GLP1 RA Dulaglutide on Severe Intracranial Atherosclerosis
Intracranial Atherosclerosis
NCT07004049 Phase 4
Recruiting
Optimising TREATment for Severe Gram-Negative Bacterial Infections
Bloodstream Infection
NCT06547372
Recruiting
Dietary Intervention on Atopy
Atopic Dermatitis
NCT06582316
Recruiting
Digital Solution for Salutogenic Brain Health (DiSaB): A Pilot Protocol for Clinical Implementation
Chronic Condition
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology